Litcius/Paper detail

Evaluating the neuroprotective activities of vinpocetine, punicalagin, niacin and vitamin E against behavioural and motor disabilities of manganese-induced Parkinson's disease in Sprague Dawley rats

Karema Abu‐Elfotuh, Ahmed M. Hamdan, Ashwaq Najemaldeen Abbas, Abdulelah Turki S. Alahmre, Mohammed A.F. Elewa, Rehab Ali Elsayed Masoud, Azza A. Ali, Mohamed S. Othman, Mona M. Kamal, Fatma Alzahraa M. Hassan, Mona G. Khalil, Ahmed M. El-Sisi, Manal M.M. Abdel Hady, Marwa Khaled Abd-Elhaleim El Azazy, Magdy M. Awny, Ahmed Wahid

2022Biomedicine & Pharmacotherapy29 citationsDOIOpen Access PDF

Abstract

(10 mg/kg, i.p) either alone (group II) or in combination with vinpocetine (VIN) (20 mg/kg) (group III), punicalagin (PUN) (30 mg/kg) (group IV), niacin (85 mg/kg) (group V), vitamin E (Vit E) (100 mg/kg) (group VI) or their combination (group VII). Motor activities was examined using open-field and catalepsy. Striatal monamines, acetylcholinesterase, excitatory/inhibitory neurotransmitters, redox status, pro-oxidant content, brain inflammatory, apoptotic and antioxidant biomarkers levels were assessed. Besides, histopathological investigations of different brain regions were determined. Groups (IV -GVII) showed improved motor functions of PD rats. Applied drugs significantly increased the brain levels of monoamines with the strongest effect to PUN. Meanwhile, they significantly decreased levels of acetylcholinesterase with a strongest effect to PUN. Moreover, they exhibited significant neuronal protection and anti-inflammatory abilities through significant reduction of the brain levels of COX2, TNF-α and Il-1β with a strongest effect to the PUN. Interestingly; groups (IV - GVII) showed restored glutamate/GABA balance and exhibited a pronounced decrease in caspase-3 content and GSK-3β protein expression levels. In addition, they significantly increased Bcl2 mRNA expression levels with a strongest effect for PUN. All these findings were further confirmed by the histopathological examinations. As a conclusion, we propose VIN and PUN to mitigate the progression of PD via their antioxidant, anti-inflammatory, anti-apoptotic, neurotrophic and neurogenic activities.

Topics & Concepts

NeuroprotectionVinpocetineAcetylcholinesteraseOxidative stressPharmacologyChemistryNiacinEndocrinologyInternal medicineMedicineBiochemistryEnzymeMedicinal Plants and NeuroprotectionConducting polymers and applicationsParkinson's Disease Mechanisms and Treatments